Skip to main content
Anticoagulation Services

Anticoagulation Services

Inpatient Anticoagulation Service

 
Management and prevention of thrombois in the Inpatient Setting is a multi-disciplinary process involving the physician, nurse, pharmacist, dietitian and clinical laboratory.  In selected situations, a designated specialist assigned to the Inpatient Antithrombosis Service will also provide support in managing or reversing anticoagulation therapy.  Physicians, pharmacists and clinical laboratory personnel who have special training in thrombosis management, have done research and published extensively on anticoagulation and related issues assist in supporting the service.  The primary purpose of this multi-disciplinary service is to improve patient outcomes, provide expert advice and consultations for patients and health care professionals, and to decrease associated costs.  This function, which includes anticoagulation and antithrombotic dosing, monitoring and education is continuously provided to patients during their hospitalization.


Anticoagulation Discharge Pharmacist

The anticoagulation discharge pharmacist is available Monday through Friday from 8:00a.m.–4:30 p.m. This service provides education for patients on anticoagulants including warfarin, LMWH, and fondaparinux. The anticoagulation discharge pharmacist will also assess if a patient qualifies for follow up in the UC Davis Anticoagulation Clinic and assist the inpatient anticoagulation pharmacist with obtainment of LMWH’s and fondaparinux for discharge if appropriate.

 

Inpatient Anticoagulation Pharmacist

The pharmacy department provides assistance with the management of anticoagulation therapy 24 hours daily. Routine monitoring of anticoagulation regimens is done daily by pharmacists assigned to either the nursing floor or the clinical service managing the patient. A specialty pharmacist is available between 7 a.m.–6 p.m. weekdays, and 
7 a.m.–5:30 p.m. weekends for assistance in anticoagulation therapy including Warfarin, Heparin, Low Molecular Weight Heparin, Direct Thrombin Inhibitors and approaches to reversal of their effects is necessary.